GenoMEL logo
 
 
  GenoMEL is an international research consortium coordinated by the University of Leeds.
  University of Leeds
  Home
  View this site in other languages
  Programme
  Membership
  Participants
  Physician Information
  Patient Information
  Papers
  Exchange Programme
  data sharing
  Knowledge Transfer
  Members Section
  Stage III Melanoma Research Group
  PharmacoGenoMEL
  Contact Us
  Site Map
  Media
  Search Site
  useful links
  News
  Accessibility
  Bestimmungen
Datenschutzbestim-
mungen
Participants
Szczecin, Poland
 
Group Details Group Members Group Publications
 
Group Details
   

Publications

 
 

Debniak T., Kurzawski G., Gorski B., Kladny J., Domagala W., Lubinski J.
Value of pedigree/clinical data, immunochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer.
Eur J. Cancer 2000; 36: 49-54.

 
 

Gorski B., Byrski T., Huzarski T., Jakubowska A., Menkiszak J., Gronwald J., Pluzanska A., Bebenek M., Fischer-Maliszewska L., Grzybowska E., Narod S.A., Lubinski J.
Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer.
Am. J. Hum. Genet. 2000; 66: 1963-1968.

 
 

Lubinski J., Gorski B., Kurzawski G., Jakubowska A., Debniak T., Cybulski C., Byrski T., Huzarski T., Kladny J., Zajaczek S., Gronwald J., Menkiszak J., Krzystolik K., Hadaczek P., Huzarska J.
Molecular analyses in diagnosis of high genetic predisposition to malignancies.
J Clin Biochem Nutr. 2000, 28, 159-165.

 
 

De los Rios P., Jack E., Kuperstein G., Lynch H., Lubinski J., Narod S.A.
Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.
Am J Hum Genet 2001, Feb 68 (2): 546.

 
 

Debniak T., Gorski B., Cybulski C., Jakubowska A., Kurzawski G., Kladny J., Lubinski J.
Comparison of Alu-PCR, microsatellite instability, and immunohistochemical analyses in finding features characteristic for hereditary nonpolyposis colorectal cancer.
J Cancer Res Clin Oncol 2001; 127: 565-569.

 
 

Grabowski M, Huzarski T, Lubinski J, Sikorski A.
Survival in patients with rare subtypes of renal cell carcinoma.
BJU Int 2002 Apr; 89 (6): 599-600.

 
 

Debniak T, Gorski B, Cybulski C, Jakubowska A, Kurzawski G, Lener M, Mierzejewski M, Masojc B, Medrek K, Kladny J, Zaluga E, Maleszka R, Chosia M, Lubinski J.
Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.
Melanoma Res. 2003 Aug; 13 (4): 365-70.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12883362&dopt=Abstract

 
 

Debniak T, Gorski B, Cybulski C, Jakubowska A, Kurzawski G, Kladny J, Zaluga E, Fiedorowicz J, Debniak B, Lubinski J.
Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation.
Eur J Cancer Prev. 2003 Jun; 12 (3): 241-5.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12771565&dopt=Abstract

 
 

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Am J Hum Genet. 2003 May; 72 (5): 1117-30. Epub 2003 Apr 03. Erratum in: Am J Hum Genet. 2003 Sep;73 (3): 709.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12677558&dopt=Abstract

 
 

Kurzawski G, Suchy J, Kladny J, Grabowska E, Mierzejewski M, Jakubowska A, Debniak, Cybulski C, Kowalska E, Szych Z, Domagala W, Scott RJ, Lubinski J.
The NOD2 3020insC mutation and the risk of colorectal cancer.
Cancer Research, 2004, 64, March 1, 64 (5): 1604-6.

 
 

Debniak T, Górski B, Cybulski C, Kurzawski G, Zlowocka E, Kladny J, Chosia M, Lubinski J.
Rarity of germline 1100delC mutation in CHEK2 in patients with malignant melanoma of the skin.
Mel Res, 2004, Apr; 14 (2): 121-4.

 
 

Cybulski C, Gorski B, Debniak T, Gliniewicz B, Mierzejewski M, Masojc B, Jakubowska A, Matyjasik J, Zlowocka E, Sikorski A, Narod SA, Lubinski J.
NBS1 is a prostate cancer susceptibility gene.
Cancer Research 2004, Feb 15; 64 (4): 1215-9.

 
 

Cybulski C, Huzarski T, Gorski B, Masojc B, Mierzejewski M, Debniak T, Gliniewicz B, Matyjasik J, Zlowocka E, Kurzawski G, Sikorski A, Posmyk M, Szwiec M, Czajka R, Narod SA, Lubinski J.
A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
Cancer Res 2004, 64 (8): 2677-9.

 
 

Debniak T, Gorski B, Scott RJ, Cybulski C, Medrek K, Zlowocka E, Kurzawski G, Debniak B, Kladny J, Bielecka-Grzela S, Maleszka R, Lubinski J.
Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer.
Int J Cancer. 2004 Jul 1; 110 (4): 558-62.

 
 

Jernstrom H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber B, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA.
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
J Natl Cancer Inst. 2004 Jul 21; 96 (14): 1094-8.

 
 

Lubinski J, Phelan CM, Ghadirian P, Lynch HT, Garber J, Weber B, Tung N, Horsman D, Isaacs C, Monteiro AN, Sun P, Narod SA.
Cancer variation associated with the position of the mutation in the BRCA2 gene.
Fam Cancer. 2004; 3 (1): 1-10.

 
 

Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Szymanska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubinski J.
CHEK2 Is a Multiorgan Cancer Susceptibility Gene.
Am J Hum Genet. 2004 Dec; 75(6):1131-5. Epub 2004 Oct 18.

 
 

Debniak T
Familial malignant melanoma - overview.
Her Can Clin Pract 2004, 2 (3): 123-130.

 
 

Debniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Debniak B, Zaluga E, Maleszka R, Kladny J, Gorski B, Cybulski C, Gronwald J, Kurzawski G, Lubinski J.
CDKN2A common variants and their association with melanoma risk: a population-based study.
Cancer Res. 2005 Feb 1; 65 (3): 835-9.

 
 

Debniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, Debniak B, Rozmiarek A, Dziuba I, Zlowocka E, Suchy J, Gorski B, Cybulski C, Mierzejewski M, Masojc B, Medrek K, Oszurek O, Lubinski J.
NOD2 variants and the risk of malignant melanoma.
Eur J Cancer Prev. 2005 Apr; 14 (2): 143-6.

 
 

Debniak T, Gorski B, Huzarski T, Byrski T, Cybulski C, Mackiewicz A, Gozdecka-Grodecka S, Gronwald J, Kowalska E, Haus O, Grzybowska E, Stawicka M, Swiec M, Urbanski K, Niepsuj S, Wasko B, Gozdz S, Wandzel P, Szczylik C, Surdyka D, Rozmiarek A, Zambrano O, Posmyk M, Narod S, Lubinski J.
A Common Variant of CDKN2A (p16) Predisposes to Breast Cancer.
J Med Genet. 2005 May 6; [Epub ahead of print].

 
 

   
   

word file Click here to download the "International Hereditary Cancer Centre - selected publications (updated in September 2005)" document.

 
 
   
 
   
website design: NKD | email: info@NKD.org.uk | site: www.NKD.org.uk